Leukemia Research
Volume 32, Issue 2 , Pages 255-261, February 2008

Imatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenic response after interferon-alpha results in a very high complete molecular response rate

  • Giuliana Alimena

      Affiliations

    • Department of Cellular Biotechnologies and Hematology, University “La Sapienza”, Rome, Italy
    • Corresponding Author InformationCorresponding author at: Department of Cellular Biotechnologies and Hematology, Via Benevento 6, 00161 Rome, Italy.
    • ,
  • Massimo Breccia

      Affiliations

    • Department of Cellular Biotechnologies and Hematology, University “La Sapienza”, Rome, Italy
    • ,
  • Luigia Luciano

      Affiliations

    • CEINGE Biotecnologie Avanzate and Department of Biochemistry and Medical Biotechnology, University of Naples Federico II, Italy
    • ,
  • Fabrizio Quarantelli

      Affiliations

    • CEINGE Biotecnologie Avanzate and Department of Biochemistry and Medical Biotechnology, University of Naples Federico II, Italy
    • ,
  • Daniela Diverio

      Affiliations

    • Department of Cellular Biotechnologies and Hematology, University “La Sapienza”, Rome, Italy
    • ,
  • Barbara Izzo

      Affiliations

    • CEINGE Biotecnologie Avanzate and Department of Biochemistry and Medical Biotechnology, University of Naples Federico II, Italy
    • ,
  • Biagio De Angelis

      Affiliations

    • CEINGE Biotecnologie Avanzate and Department of Biochemistry and Medical Biotechnology, University of Naples Federico II, Italy
    • ,
  • Marco Mancini

      Affiliations

    • Department of Cellular Biotechnologies and Hematology, University “La Sapienza”, Rome, Italy
    • ,
  • Roberto Latagliata

      Affiliations

    • Department of Cellular Biotechnologies and Hematology, University “La Sapienza”, Rome, Italy
    • ,
  • Ida Carmosino

      Affiliations

    • Department of Cellular Biotechnologies and Hematology, University “La Sapienza”, Rome, Italy
    • ,
  • Mauro Nanni

      Affiliations

    • Department of Cellular Biotechnologies and Hematology, University “La Sapienza”, Rome, Italy
    • ,
  • Marco Picardi

      Affiliations

    • CEINGE Biotecnologie Avanzate and Department of Biochemistry and Medical Biotechnology, University of Naples Federico II, Italy
    • ,
  • Bruno Rotoli

      Affiliations

    • CEINGE Biotecnologie Avanzate and Department of Biochemistry and Medical Biotechnology, University of Naples Federico II, Italy
    • ,
  • Franco Mandelli

      Affiliations

    • Department of Cellular Biotechnologies and Hematology, University “La Sapienza”, Rome, Italy
    • ,
  • Fabrizio Pane

      Affiliations

    • CEINGE Biotecnologie Avanzate and Department of Biochemistry and Medical Biotechnology, University of Naples Federico II, Italy

Received 8 April 2007; received in revised form 4 June 2007; accepted 6 June 2007. published online 07 March 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(07)00250-0

doi:10.1016/j.leukres.2007.06.008

Leukemia Research
Volume 32, Issue 2 , Pages 255-261, February 2008

Article Tools

* Image Usage & Resolution